A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis

Clinical trial NCT07250750 · RECRUITING

Trial details

NCT number: NCT07250750
Sponsor: ImmunAbs Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myasthenia Gravis

Start date: 2026-02-05
Primary completion: 2027-12-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.